This is a prospective, randomized, open label, blinded-end point, single-center study, aiming to investigate the effect of head down position in anterior circulation large vessel occlusion patients with successful recanalization after endovascular treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
90
-10° Trendelenburg
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China
Changes in National Institute of Health stroke scale (NIHSS)
the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome.
Time frame: 24±8 hours
proportion of excellent functional outcome
excellent functional outcome is defined as modified Rankin Score (mRS) 0-1. The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome
Time frame: 90±7 days
proportion of favorable functional outcome
favorable functional outcome defined as modified Rankin Score (mRS) 0-2. The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome
Time frame: 90±7 days
ordinal distribution of modified Rankin Score (mRS)
The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome
Time frame: 90±7 days
early neurological improvement (ENI)
ENI is defined as more than 8-point decrease in NIHSS or 0 NIHSS within 24±8 hours
Time frame: 24±8 hours
changes in infarct volume
infarct volume is measured by diffused weighted imaging
Time frame: 24±8 hours
changes in cerebral edema
cerebral edema is determined by brain imaging
Time frame: 24±8 hours
Changes in National Institute of Health stroke scale (NIHSS)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome.
Time frame: 10±2 days
new stroke or other vascular event(s)
Time frame: 90±7 days
proportion of sympomatic intracranial hemorrhage
sympomatic intracranial hemorrhage is defined as a NIHSS increase ≥4 caused by intracranial hemorrhage
Time frame: 24±8 hours
proportion of intraparenchymal hemorrhage (PH)
PH was defined as confluent bleeding occupying and causing mass effect
Time frame: 24±8 hours
percentage of severe adverse events
Time frame: 24±8 hours
all-cause mortality
Time frame: 90±7 days